🇺🇸 FDA
Pipeline program

dydrogesterone

SPS2016-01

Phase 3 small_molecule completed

Quick answer

dydrogesterone for Preterm Delivery is a Phase 3 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Preterm Delivery
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials